Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8537916rdf:typepubmed:Citationlld:pubmed
pubmed-article:8537916lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:8537916lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:8537916lifeskim:mentionsumls-concept:C0021753lld:lifeskim
pubmed-article:8537916lifeskim:mentionsumls-concept:C0005974lld:lifeskim
pubmed-article:8537916lifeskim:mentionsumls-concept:C0074529lld:lifeskim
pubmed-article:8537916lifeskim:mentionsumls-concept:C1440080lld:lifeskim
pubmed-article:8537916lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:8537916pubmed:issue9lld:pubmed
pubmed-article:8537916pubmed:dateCreated1996-2-8lld:pubmed
pubmed-article:8537916pubmed:abstractTextThe effects of recombinant human interleukin-1 beta (rhIL-1 beta) on alveolar bone resorptive activity in rats were examined. Continuous administration of rhIL-1 beta or phosphate-buffered saline (PBS) was given via osmotic pumps for 3, 7 and 14 days to rats with silk ligatures around second maxillary molars. Other animals without ligatures received insertion of pumps containing rhIL-1 beta or remained untreated. Sections were subject to three different stains:--hematoxylin and eosin (H-E) for histology, acid phosphatase (ACPase) activity for osteoclast detection, and immunohistochemistry using anti-rat monocyte/macrophage monoclonal antibody (ED 1). In addition, body weight, plasma calcium and phosphorus levels were monitored. The mean body weight of rats receiving rhIL-1 beta was significantly lower (P < 0.05 to P < 0.01) compared with untreated rats throughout the experimental period. On Day 7, plasma calcium and phosphorus levels were significantly lower in rats receiving rhIL-1 beta than in rats receiving PBS only (P < 0.05). Sections revealed a moderate inflammatory cell infiltrate reaching near the alveolar crest in both groups with ligatures on Day 3. Only rats receiving rhIL-1 beta exhibited enhancement of inflammatory cell invasion on Days 7 and 14. In rats receiving rhIL-1 beta with ligatures, numerous resorption lacunae containing ACPase-positive multinucleated giant cells (MNGCs), coinciding with ED1-positive cells, were located on the mesial side of the septum where extensive bone resorption had occurred throughout the experimental period. In animals receiving rhIL-1 beta without ligatures, compared with untreated rats, increased ACPase-positive cells were observed on the mesial side of the septum on Day 3. In animals receiving PBS only, a few ACPase-positive cells were observed confined to the mesial regions where slight bone resorption occurred on Days 7 and 14. These results indicate that the administration of rhIL-1 beta accelerated alveolar bone destruction in ligature-induced periodontal tissue inflammation over a two-week period.lld:pubmed
pubmed-article:8537916pubmed:languageenglld:pubmed
pubmed-article:8537916pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8537916pubmed:citationSubsetDlld:pubmed
pubmed-article:8537916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8537916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8537916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8537916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8537916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8537916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8537916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8537916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8537916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8537916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8537916pubmed:statusMEDLINElld:pubmed
pubmed-article:8537916pubmed:monthOctlld:pubmed
pubmed-article:8537916pubmed:issn0904-2512lld:pubmed
pubmed-article:8537916pubmed:authorpubmed-author:SuzukiTTlld:pubmed
pubmed-article:8537916pubmed:authorpubmed-author:OnoYYlld:pubmed
pubmed-article:8537916pubmed:authorpubmed-author:HaraKKlld:pubmed
pubmed-article:8537916pubmed:authorpubmed-author:TakaiMMlld:pubmed
pubmed-article:8537916pubmed:authorpubmed-author:TaniguchiYYlld:pubmed
pubmed-article:8537916pubmed:authorpubmed-author:SaitohSSlld:pubmed
pubmed-article:8537916pubmed:authorpubmed-author:YoshieHHlld:pubmed
pubmed-article:8537916pubmed:authorpubmed-author:KoideMMlld:pubmed
pubmed-article:8537916pubmed:authorpubmed-author:SudaSSlld:pubmed
pubmed-article:8537916pubmed:authorpubmed-author:OfujiYYlld:pubmed
pubmed-article:8537916pubmed:issnTypePrintlld:pubmed
pubmed-article:8537916pubmed:volume24lld:pubmed
pubmed-article:8537916pubmed:ownerNLMlld:pubmed
pubmed-article:8537916pubmed:authorsCompleteYlld:pubmed
pubmed-article:8537916pubmed:pagination420-34lld:pubmed
pubmed-article:8537916pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:meshHeadingpubmed-meshheading:8537916-...lld:pubmed
pubmed-article:8537916pubmed:year1995lld:pubmed
pubmed-article:8537916pubmed:articleTitleIn vivo administration of IL-1 beta accelerates silk ligature-induced alveolar bone resorption in rats.lld:pubmed
pubmed-article:8537916pubmed:affiliationDepartment of Periodontology, Niigata University School of Dentistry, Japan.lld:pubmed
pubmed-article:8537916pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8537916lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8537916lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8537916lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8537916lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8537916lld:pubmed